mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.02 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
AZD6244 |
FIMM |
pan-cancer |
AAC |
-0.41 |
0.02 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |